NCT03238248 2024-11-04
Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
Vanderbilt-Ingram Cancer Center
Boehringer Ingelheim
AstraZeneca